DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)

43 filings reported holding DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value as of Q1 2021.
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5,694,347 shares of 51,654,406 outstanding shares and own 11.02% of the company stock.
Largest 10 shareholders include Stonepine Capital Management, LLC (1,023,409 shares), Corriente Advisors, LLC (870,228 shares), VANGUARD GROUP INC (846,266 shares), Manatuck Hill Partners, LLC (570,500 shares), Point72 Asset Management, L.P. (552,250 shares), Ikarian Capital, LLC (415,000 shares), JACOB ASSET MANAGEMENT OF NEW YORK LLC (185,000 shares), Granite Point Capital Management, L.P. (184,380 shares), RENAISSANCE TECHNOLOGIES LLC (153,100 shares), and GEODE CAPITAL MANAGEMENT, LLC (128,468 shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.